A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma

Clinical trial NCT01596270 · COMPLETED

Trial details

NCT number: NCT01596270
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neoplasm Malignant

Start date: 2012-06-01
Primary completion: 2014-10-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.